Entry Point Capital, LLC Ani Pharmaceuticals Inc Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Entry Point Capital, LLC holds 2,724 shares of ANIP stock, worth $159,381. This represents 0.25% of its overall portfolio holdings.
Number of Shares
2,724Holding current value
$159,381% of portfolio
0.25%Shares
2 transactions
Others Institutions Holding ANIP
# of Institutions
206Shares Held
15MCall Options Held
24KPut Options Held
7.7K-
Black Rock Inc. New York, NY2.66MShares$155 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.44MShares$84.3 Million0.0% of portfolio
-
State Street Corp Boston, MA645KShares$37.7 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX630KShares$36.9 Million0.01% of portfolio
-
Rubric Capital Management LP New York, NY604KShares$35.3 Million1.14% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.02B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...